Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 564 of 6351
-
Mass STI treatment or pill after sex? major trial tests best bet for kenyan men
Disease control Recruiting nowMen who have sex with men (MSM) are at high risk for gonorrhea and chlamydia in Kenya, where nucleic acid amplification testing is not feasible and most infections therefore go undiagnosed. We propose an open-label randomized clinical trial with 2900 participants assigned to WHO-…
Phase 4 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Gene therapy trial aims to help people with angelman syndrome communicate better
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of MVX-220 gene therapy in children and adults with Angelman syndrome with UBE3A gene deletion, uniparental disomy, or imprinting center defect genotypes.
Phase 1/2 • Sponsor: MavriX Bio, LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Personalized cancer test could match patients to best drugs
Diagnosis Recruiting nowDSEE-CRC is a top-tier Norwegian and Swedish public-private partnership for the development of µCAN, a unique patient-centric, therapy-guiding in vitro diagnostic test to improve cancer treatment outcomes for metastatic colorectal cancer patients. µCAN takes a cancer biopsy sampl…
Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Glaucoma patients may soon ditch eye drops after cataract surgery
Disease control Recruiting nowThis trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Phase 3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New Dual-Targeting CAR t therapy takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis study is a single-center, open and dose-escalation clinical study to evaluate the safety, tolerability, PK/PD characteristics and preliminary efficacy of the investigational drug O\&D-001 injection in the treatment of relapsed or refractory multiple myeloma.
Phase 1 • Sponsor: O&D BioTech Group CO., Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immunotherapy after surgery may keep early lung cancer at bay
Disease control Recruiting nowA Randomized, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New eye injection aims to halt blindness from dry AMD in major trial
Disease control Recruiting nowThe purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment frequencies in patients with GA associated with AMD. GA associated with AMD is one of the world's leading…
Phase 2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat solid tumors
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, safety, and ORR of HRS-4508 combination with other anti tumor therapy in subjects with solid tumor ; to evaluate HRS-4508 DLT, MTD and RP2D, to evaluate the incidence and severity of adverse events (AE)/serious adverse events…
Phase 1/2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a simple steroid keep kids off ventilators longer?
Prevention Recruiting nowFifty to 60% of children admitted to a pediatric intensive care unit (PICU) are placed under invasive mechanical ventilation (MV) at least once during their stay. After extubation, about 30% of these patients will experience respiratory distress due to upper airway obstruction (R…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
New drug combo shows promise in shrinking cervical tumors before surgery
Disease control Recruiting nowCervical cancer ranks as the second most common malignancy of the female genital tract. According to the World Health Organization, there are 530,000 new cases and approximately 250,000 cervical-cancer-related deaths worldwide each year, with 80% of these deaths occurring in wome…
Phase 2 • Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Magic mushroom therapy could help cut opioid dependence in chronic pain patients
Symptom relief Recruiting nowThis is an open-label pilot trial to assess the safety and feasibility of a novel 8-week psilocybin-assisted psychotherapy intervention to facilitate successful tapering/discontinuation of opioid pain medication in adult patients receiving long-term opioid therapy for chronic pai…
Phase 2 • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New combo aims to shrink rectal tumors without surgery
Disease control Recruiting nowPrimary Objectives: Evaluate the complete response rate (CR rate) and safety of short - course radiotherapy combined with ivonesimab (AK112) in patients with pMMR/MSS mid - low rectal cancer. Secondary Objectives: Evaluate treatment - related toxic reactions, the quality of life…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Mpox vaccine gets a production upgrade: new cell recipe under trial
Vaccine OngoingRandomized, double-blind, phase 2b trial to assess comparability in immunogenicity, safety, and reactogenicity of MVA-BN vaccine manufactured in primary chicken embryo fibroblast (CEF) cells and the CCX.E10 quail cell line in adults
Phase 2 • Sponsor: Bavarian Nordic • Aim: Vaccine
Last updated Jun 27, 2026 12:05 UTC
-
Could a simple Anti-Inflammatory drug save lives after aortic tear?
Disease control Recruiting nowThis multicenter, randomized, double-blind, placebo-controlled trial evaluates the efficacy and safety of ketorolac in 1,346 patients with Stanford Type A aortic dissection, conducted between 2025 and 2028. Participants will receive either ketorolac (60 mg intramuscularly \[IM\] …
Phase 3 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for women with Hard-to-Treat breast cancer: drug combo trial launches
Disease control Recruiting nowThe DIAMOND study is being carried out to evaluate if Datopotamab deruxtecan (Dato-DX) in combination with Durvalumab is more effective than Dato-DXd alone in treating PDL1-negative advanced or metastatic triple negative breast cancer (TNBC). Globally, breast cancer is the most c…
Phase 2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
TB prevention for kids: immediate treatment may stop infection before it starts
Prevention Recruiting nowThe goal of this cluster-randomized controlled trial is to evaluate the effectiveness of tuberculosis preventive treatment (TPT) administered during the "window period" to prevent new Mycobacterium tuberculosis infections in children and adolescents. The main question it aims to…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy targets breast cancer cells in the brain
Disease control Recruiting nowEvaluate the efficacy and safety of Intrathecal Administration of Thiotepa in Combination with Trastuzumab via the Ommaya Reservoir in Breast Cancer with Leptomeningeal Metastasis
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo aims to fight Hard-to-Treat colorectal cancer
Disease control Recruiting nowA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer
Phase 2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Lab test could match cancer patients to the right drugs
Knowledge-focused OngoingThe goal of this clinical trial is to learn whether a new laboratory method called OPTin can help doctors select the most effective, personalized cancer therapies for patients with advanced or treatment-resistant tumors. The study will also learn about the safety and feasibility …
Sponsor: China Medical University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New daily pill HEC585 aims to slow lung scarring in IPF
Disease control Recruiting nowA multicenter, parallel, randomized, placebo (double-blind) and pirfenidone (open-label) controlled Phase III clinical trial to evaluate the efficacy and safety of HEC585 in patients with idiopathic pulmonary fibrosis (IPF)
Phase 3 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC